NewBridge Pharmaceuticals
NBP was founded in 2010 to be the First-in-Class commercialization platform for the Middle East and North Africa region, focusing on in-licensing only innovative therapies developed by Global Pharma, with a mission to bridge the access gap in the region
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}